<!DOCTYPE html>
<html>
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta http-equiv="X-UA-Compatible" content="ie=edge">
<title>Markmap</title>
<style>
* {
  margin: 0;
  padding: 0;
}
#mindmap {
  display: block;
  width: 100vw;
  height: 100vh;
}
</style>
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/markmap-toolbar@0.17.3-alpha.1/dist/style.css">
</head>
<body>
<svg id="mindmap"></svg>
<script src="https://cdn.jsdelivr.net/npm/d3@7.9.0/dist/d3.min.js"></script><script src="https://cdn.jsdelivr.net/npm/markmap-view@0.17.3-alpha.1/dist/browser/index.js"></script><script src="https://cdn.jsdelivr.net/npm/markmap-toolbar@0.17.3-alpha.1/dist/index.js"></script><script>(()=>{setTimeout(()=>{const{markmap:q,mm:v}=window,j=new q.Toolbar;j.attach(v);const we=j.render();we.setAttribute("style","position:absolute;bottom:20px;right:20px"),document.body.append(we)})})()</script><script>((f,d,h,u)=>{const g=f();window.mm=g.Markmap.create("svg#mindmap",(d||g.deriveOptions)(u),h)})(()=>window.markmap,null,{"content":"SAbDab in the Age of Biotherapeutics: Updates Including SAbDab-nano, the Nanobody Structure Tracker","children":[{"content":"Introduction","children":[{"content":"ğŸ“š Antibodies as Biotherapeutics","children":[{"content":"ğŸ’° 100th monoclonal antibody approved by FDA","children":[],"payload":{"lines":"4,5"}},{"content":"ğŸ’µ $110.6 billion sales in 2019 from top antibody therapeutics","children":[],"payload":{"lines":"5,6"}}],"payload":{"lines":"3,6"}},{"content":"ğŸ§¬ Importance of Antibody Structure","children":[{"content":"ğŸ” Understanding 3D structure for therapeutic development","children":[],"payload":{"lines":"7,8"}},{"content":"ğŸ“ˆ Growth of Structural Antibody Database (SAbDab) since 2013","children":[],"payload":{"lines":"8,10"}}],"payload":{"lines":"6,10"}}],"payload":{"lines":"2,3"}},{"content":"Key Updates to SAbDab","children":[{"content":"ğŸ”„ Continuous Database Improvements","children":[{"content":"ğŸ—“ï¸ Weekly updates to SAbDab and SAbDab-nano","children":[],"payload":{"lines":"12,13"}},{"content":"ğŸ“Š Increase in antibody structures from 1624 to 5426","children":[],"payload":{"lines":"13,14"}}],"payload":{"lines":"11,14"}},{"content":"ğŸ§ª Development of SAbDab-nano","children":[{"content":"ğŸ” Focus on nanobodies (heavy chain-only antibodies)","children":[],"payload":{"lines":"15,16"}},{"content":"ğŸ“ˆ Significant growth in interest from research communities","children":[],"payload":{"lines":"16,18"}}],"payload":{"lines":"14,18"}}],"payload":{"lines":"10,11"}},{"content":"Updates to Data Annotation","children":[{"content":"ğŸ“ Enhanced Annotation Features","children":[{"content":"ğŸ§¬ Structure details: name, species, experimental method, resolution","children":[],"payload":{"lines":"20,21"}},{"content":"ğŸ”— Links to auxiliary databases (Thera-SAbDab, CoV-AbDab)","children":[],"payload":{"lines":"21,22"}}],"payload":{"lines":"19,22"}},{"content":"ğŸ“Š Dataset Creation","children":[{"content":"ğŸ“¥ Ability to create datasets based on specific search criteria","children":[],"payload":{"lines":"23,24"}},{"content":"ğŸ“¬ New email alert feature for structure updates","children":[],"payload":{"lines":"24,26"}}],"payload":{"lines":"22,26"}}],"payload":{"lines":"18,19"}},{"content":"Data Access and Search Interface","children":[{"content":"ğŸ” Improved Search Capabilities","children":[{"content":"âš™ï¸ Flask app for structure retrieval and search criteria","children":[],"payload":{"lines":"28,29"}},{"content":"ğŸ”‘ Free-text keyword search for specific attributes","children":[],"payload":{"lines":"29,30"}}],"payload":{"lines":"27,30"}},{"content":"ğŸ“¦ Bulk Download Options","children":[{"content":"ğŸ—‚ï¸ Download all structures matching search queries as zipped archives","children":[],"payload":{"lines":"31,33"}}],"payload":{"lines":"30,33"}}],"payload":{"lines":"26,27"}},{"content":"SAbDab-nano","children":[{"content":"ğŸ“ˆ Growth of Nanobody Structures","children":[{"content":"ğŸŒ± 823 structures in SAbDab-nano as of September 2021","children":[],"payload":{"lines":"35,36"}},{"content":"ğŸ” Majority resolved in complex with protein antigens","children":[],"payload":{"lines":"36,37"}}],"payload":{"lines":"34,37"}},{"content":"ğŸ“Š Comparison with Other Resources","children":[{"content":"ğŸš« Lack of continuously updated nanobody structure resources","children":[],"payload":{"lines":"38,39"}},{"content":"ğŸ”— Other databases focus on sequences, not structures","children":[],"payload":{"lines":"39,41"}}],"payload":{"lines":"37,41"}}],"payload":{"lines":"33,34"}},{"content":"Conclusion","children":[{"content":"ğŸ”„ Continual Updates and Accessibility","children":[{"content":"ğŸŒ SAbDab and SAbDab-nano available under CC-BY 4.0 license","children":[],"payload":{"lines":"43,44"}},{"content":"ğŸ“¡ Integration with SAbBox for advanced dataset creation","children":[],"payload":{"lines":"44,46"}}],"payload":{"lines":"42,46"}}],"payload":{"lines":"41,42"}},{"content":"Acknowledgements","children":[{"content":"ğŸ™ Thanks to Dr. Claire Marks for contributions to SAbDab","children":[],"payload":{"lines":"47,49"}}],"payload":{"lines":"46,47"}},{"content":"Funding and Conflict of Interest","children":[{"content":"ğŸ’° Funded by Engineering and Physical Sciences Research Council","children":[],"payload":{"lines":"50,51"}},{"content":"âš–ï¸ No declared conflicts of interest","children":[],"payload":{"lines":"51,52"}}],"payload":{"lines":"49,50"}}],"payload":{"lines":"0,1"}},null)</script>
</body>
</html>
